JPS5845557A - Reagent for quantitative determination of hydrogen peroxide - Google Patents

Reagent for quantitative determination of hydrogen peroxide

Info

Publication number
JPS5845557A
JPS5845557A JP14392481A JP14392481A JPS5845557A JP S5845557 A JPS5845557 A JP S5845557A JP 14392481 A JP14392481 A JP 14392481A JP 14392481 A JP14392481 A JP 14392481A JP S5845557 A JPS5845557 A JP S5845557A
Authority
JP
Japan
Prior art keywords
reagent
compound
hydrogen peroxide
substance
peroxidase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP14392481A
Other languages
Japanese (ja)
Other versions
JPH0218840B2 (en
Inventor
Eigou Yuki
英剛 由岐
▲さい▼藤 仁俊
Hitotoshi Saitou
Kazuyoshi Nishidate
西館 和由
Norimasa Takizawa
滝沢 徳正
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
YATORON KK
Mitsubishi Kagaku Iatron Inc
Original Assignee
YATORON KK
Mitsubishi Kagaku Iatron Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by YATORON KK, Mitsubishi Kagaku Iatron Inc filed Critical YATORON KK
Priority to JP14392481A priority Critical patent/JPS5845557A/en
Publication of JPS5845557A publication Critical patent/JPS5845557A/en
Publication of JPH0218840B2 publication Critical patent/JPH0218840B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/28Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase

Abstract

PURPOSE:To obtain a reagent easy to prepare a uniform aqueous solution and having no influence on the activity of enzyme and also, having good reproducibility, by using specific triaryl imidazole derivative etc. having a sulfonic acid radical or carboxyl group. CONSTITUTION:A compound expressed by the general formula in the figure (wherein R<1> is -H, -OCH3-CH3, R<2> is -CH3,-C2H5, R<3> is -(CH2)n-SO3H or -(CH2)n- COOH and n=1-3) or its salt, is incorporated as a color forming agent. For example, a reagent is constituted by desired reagent components participating in a series of reaction which produce hydrogen peroxide finally by acting to a substance and peroxidase or the substance acting like peroxidase and also, said compound. Said compound is used effectively for the determination of trace components because it is easily soluble in water and the maximum absorption wavelength of coloring matter produced by reacting with hydrogen peroxide is 610mm. and said compound is not affected by the substance having an absorption band in a short wavelength e.g. bilirubin, hemoglobin etc. at measurement and moreover, it has a high molecular absorption coefficient.

Description

【発明の詳細な説明】 本発明は過酸化水素定量用試薬Kかんする。[Detailed description of the invention] The present invention relates to a reagent K for quantifying hydrogen peroxide.

過酸化水素の検出および定量は、従来から種々の分野で
さまざまな方法で行われているが、臨床−検査の分野に
おいて、その重畳性は、ここ数年来とみに増している。
Detection and quantification of hydrogen peroxide has traditionally been carried out in various fields using various methods, but in the field of clinical testing, its overlapping nature has increased significantly over the past few years.

すなわち生体液試料中の成分に酵累を作用させ、生成す
る過酸化水素を測定し、当該成分を定量する方法が広く
行われている。このことは、生体液中の微量成分である
グルコース、コレステロール、尿酸、リン脂質、中性脂
肪、遊離脂肪酸等の測定を容易にし、臨床診断等に利用
することで、その有効性が十分に立証されている。
That is, a widely used method is to apply fermentation to a component in a biological fluid sample, measure the generated hydrogen peroxide, and quantify the component. This makes it easy to measure trace components such as glucose, cholesterol, uric acid, phospholipids, neutral fats, and free fatty acids in biological fluids, and its effectiveness has been fully demonstrated by using it for clinical diagnosis. has been done.

このような過酸化水素の検定及び定量法に用いられてい
る試薬は、過酸化水素をノ譬−オキシダーゼまたはパー
オキシダーゼよつ作用を有する物質の存在下で反応させ
、発色あるいは発螢光に導くことが可能な水素供与体を
含むもので、それらについては数多くの開発がなされて
いる。大別すると、 (1)  酸化還元色素を用いる方法で、還元型の色素
を酸化し発色させて測定する方法。例えば、還元型2.
6−シクロルフエノールインドフエノール、ロイコマラ
カイトグリーン等がある。
The reagent used in such hydrogen peroxide assay and quantitative methods involves reacting hydrogen peroxide in the presence of an oxidase or a substance that acts like peroxidase, leading to color development or fluorescence. A number of developments have been made regarding these hydrogen donors. Broadly divided: (1) A method that uses redox dyes, in which the reduced dye is oxidized to develop color for measurement. For example, reduced type 2.
Examples include 6-cyclophenol indophenol and leucomalachite green.

(2)  酸化縮合による発色を測定する方法。例えば
、4−メトキシナフトールを用いそれ自身の酸化縮合に
よる発色を測定する方法、またデベロッパーとして、4
−アミノアンチピリンまたは3−メチル−2−ベンゾチ
アゾロンヒドラゾンな用い、カップラーとしてアニリン
系化合物あるいはフェノール系化合物を用い両者の間で
酸化縮合を行わせ、その際の発色を一定する方法がある
(2) A method of measuring color development due to oxidative condensation. For example, 4-methoxynaphthol is used to measure the color development due to its own oxidative condensation, and 4-methoxynaphthol is used as a developer.
-aminoantipyrine or 3-methyl-2-benzothiazolone hydrazone, or use an aniline compound or a phenol compound as a coupler to carry out oxidative condensation between the two, and there is a method in which color development is constant.

しかし、これらの方法は、いずれも完全なものではなく
、*に生体液中成分の測定においては、感度、安定性、
測定波長、水溶性、毒性の点でいずれかの欠点を持って
いる。
However, none of these methods is perfect, and there are issues with sensitivity, stability, and
They have some drawbacks in terms of measurement wavelength, water solubility, and toxicity.

本発明者等はこれらの欠点を除くべく種々研究を重ねた
結果こパーオキシダーゼの存在下で高感度、長波長で測
定可能な、さらに発色の安定性がよく、しかも水溶性で
ある発色剤を合成した。これKより分散剤等を用いるこ
となく均一な水溶液の調製が可能となり、しかも酵素活
性に対し影響のない再現性の良い試薬を開発し、本発明
を完成した。
As a result of various studies to eliminate these drawbacks, the present inventors have developed a color former that can be measured with high sensitivity and long wavelengths in the presence of peroxidase, has good color stability, and is water-soluble. Synthesized. From this K, we have developed a reagent that enables the preparation of a uniform aqueous solution without using a dispersant or the like and has good reproducibility without affecting enzyme activity, thereby completing the present invention.

本発明に従って、次の一般式で表わされる化合物、ある
いはその塩を発色剤として含有することを特徴とする液
体中の過酸化水素定量用試薬: (ここでR1は−H,−0CR,、−CH。
According to the present invention, a reagent for quantifying hydrogen peroxide in a liquid, which is characterized by containing a compound represented by the following general formula or a salt thereof as a coloring agent: (where R1 is -H, -0CR, - CH.

R” バーCHs 、 −Ct Is R畠は−PCB、丸5osHまたは +CH2+nCool(でn = 1〜3を表わす)が
提供される。
R'' bar CHs, -Ct Is R field is provided with -PCB, circle 5osH or +CH2+nCool (representing n = 1 to 3).

本発明における発色剤化合物は一般式に示す通り、スル
ホン酸基または、カル?キシル基を有するトリアリール
イミダゾール誘導体であるが、これに類似のトリアリー
ルイミダゾール染料前駆体が公開特許公報昭53−26
188に開示されている。しかし、当該公報から明らか
な通り当該トリアリールイミダゾール染料前駆体にはス
ルホン酸基またはカルがキシル基を有する化合物は全く
含まれていない。しかも、当該公報に記載の化合物は水
に対して不溶または難溶性物質であり、水浴性の具体的
物質名は示されていない。
As shown in the general formula, the color former compound in the present invention has a sulfonic acid group or a carboxyl group. It is a triarylimidazole derivative having a xyl group, and a triarylimidazole dye precursor similar to this is disclosed in Japanese Patent Application Publication No. 53-26-1981.
188. However, as is clear from the publication, the triarylimidazole dye precursor does not contain any compound having a sulfonic acid group or a xyl group. Moreover, the compounds described in this publication are insoluble or poorly soluble substances in water, and the names of specific water bathing substances are not indicated.

一般的に過酸化水素の存在または生成する試料は水浴液
の状態で反応さ尋る方法をとるのが大部分であり、その
定量用試薬も取扱い上水溶液が好ましい。また液体と固
体を反応させる方法より、液体と液体を混合し反応させ
る方法がより迅速でしかも再現性が喪好であるといえる
し、本発明者等が水溶性を重視した所以である。
Generally, in most cases, a sample in which hydrogen peroxide is present or generated is reacted in a water bath state, and the quantitative reagent is preferably an aqueous solution for handling purposes. Furthermore, it can be said that a method of mixing and reacting a liquid and a liquid is faster than a method of reacting a liquid and a solid, and has poor reproducibility, which is why the inventors of the present invention placed importance on water solubility.

本発明の化合物は極めて水溶性がよく、さらに過酸化水
素と反応して生成する色素の極大吸収波長が610 n
m であるので、測定に際し短波長和吸収のある物質、
例えばビリルビン、ヘモグロビン等の影響を受けない。
The compound of the present invention has extremely good water solubility, and the maximum absorption wavelength of the dye produced by reacting with hydrogen peroxide is 610 nm.
m, so when measuring, a substance with short wavelength sum absorption,
For example, it is not affected by bilirubin, hemoglobin, etc.

また、その分子吸光係数が4〜6万eR″/−oI M
/lであるので微量成分の定量には効果的である。
In addition, its molecular extinction coefficient is 40,000 to 60,000 eR''/-oI M
/l, so it is effective for quantifying trace components.

本発明の化合物は一般に周知の次の方法で合成すること
ができる。
The compounds of the present invention can be synthesized by the following generally known methods.

例えば、 (1) 120〜125cつ阜 4時間 KF/ジオキサン CtCFI、 cn、 so、α αCM、CH,80,F    (2)(COα)。for example, (1) 120~125cm 4 hours KF/dioxane CtCFI, cn, so, α αCM, CH, 80, F (2) (COα).

の合成工程を経て得られた。It was obtained through the synthesis process of

次K、本発明化合物の水溶性について、類似のトリアリ
ールイミダゾール染料前部物質の一部と比較した試験結
果を表−IK示す。
Table IK shows test results for the water solubility of the compounds of the present invention in comparison with some similar triarylimidazole dye front materials.

表−1より明らかなように、2 、3 、4 、5゜6
,7は水溶性であり、その反応生成物の色調も安定であ
った。過酸化水素の検出又は定ilK際し、本発明化合
物を用いる場合の緩衝液のpnは約6ないし8.5の範
囲内が適当で、例えば、リン酸塩緩衝液、ホウ酸塩緩衝
液、クエン酸塩緩衝液、コハク酸塩緩衝液、トリス緩衝
液、グリシン緩衝液、トリエタノールアミン緩衝液、マ
クイルパイン緩衝液、グツド緩衝液等を用いることがで
きる。
As is clear from Table 1, 2, 3, 4, 5゜6
, 7 was water-soluble, and the color tone of the reaction product was also stable. When detecting or determining ilK of hydrogen peroxide, the pn of the buffer when using the compound of the present invention is suitably within the range of about 6 to 8.5, such as phosphate buffer, borate buffer, Citrate buffer, succinate buffer, Tris buffer, glycine buffer, triethanolamine buffer, maquipine buffer, Gud buffer, etc. can be used.

グルコースを測定する場合は、グルコースオキシダーゼ
とパーオキシダーゼを作用させ、pn 6〜7のリン酸
塩緩衝液中で行うことが好ましい。
When measuring glucose, it is preferable to allow glucose oxidase and peroxidase to interact in a phosphate buffer solution of pn 6 to 7.

コレステロールを測定する場合はコレステロールオキシ
ダーゼとパーオキシダーゼヲ作用させ、pH6〜7のリ
ン酸塩緩衝液中で行うことが好ましい。
When measuring cholesterol, it is preferable to allow cholesterol oxidase and peroxidase to interact in a phosphate buffer solution having a pH of 6 to 7.

リン脂質を測定する場合は、ホス7オリノぐ−ゼDとコ
リンオキシダーゼおよびノや−オキシダーせを作用させ
、p118のトリス緩衝液中で行うことが好ましい。
When measuring phospholipids, it is preferable to allow phos-7 orinogase D to interact with choline oxidase and noya-oxidase in a p118 Tris buffer.

中性脂肪を測定する烏合はリポプロテインリパーヤとグ
リセロキナーゼとL−α−グリセロリン酸オキシダーゼ
、およびパーオキシダーゼを作用させpH7のグツド緩
衝液中で行うことが好ましい。
Preferably, the measurement of neutral fat is carried out in a pH 7 buffer solution with the action of lipoprotein lipid, glycerokinase, L-α-glycerophosphate oxidase, and peroxidase.

遊離脂肪酸を測定する場合は、アシルCoAシンセター
ゼとアシルCoAオキシダーゼ、および/々−オキシダ
ーゼを作用させpH6〜8のグツド緩衝液中で行うこと
が好ましい。
When measuring free fatty acids, it is preferable to carry out the measurement in a good buffer solution having a pH of 6 to 8, in which acyl-CoA synthetase, acyl-CoA oxidase, and/or oxidase are allowed to act.

尿酸を測定する場合はウリカーゼと/f−オキシダーゼ
を作用させ、pH6〜7のホウ酸塩緩衝液中で行うこと
が好ましい。
When measuring uric acid, it is preferable to allow uricase and /f-oxidase to act in a borate buffer solution of pH 6 to 7.

また、コリンエステラーゼ活性モ、ペンソイルコリンを
基質とし、コリンオキシダーゼとパーオキシダーゼを作
用させて8I11定することが可能で島本。
In addition, Shimamoto said it is possible to determine 8I11 by using cholinesterase activity, pensoylcholine as a substrate, and choline oxidase and peroxidase.

次KiJ!施例により本発明を説明する。Next KiJ! The invention will be explained by examples.

(1)  試薬: 70 m mol/Lホウ酸塩緩衝
液(pH6)に/ぐ−オキシダーゼを0.5U/d、本
発明化合物(A4(表−1参照> 50μmol/1l
fcなるように調製した。
(1) Reagents: 70 mmol/L borate buffer (pH 6), 0.5 U/d of oxidase, and the compound of the present invention (A4 (see Table 1) > 50 μmol/1 L
fc.

(2)試料液:市販、過酸化水累水を用い2.0゜1.
6 e l−4e O08g O−4m mol/lに
なるように水で希釈調製した。
(2) Sample solution: Commercially available, accumulated water peroxide was used at 2.0°1.
It was diluted with water to give 6 e l-4e O08g O-4m mol/l.

(3)操作:試薬3.0−と試料液のそれぞれを20μ
を加え、37℃で5分間加温し、波長610 nm の
吸光度を測定した。
(3) Operation: 20μ each of reagent 3.0- and sample solution
was added, heated at 37°C for 5 minutes, and absorbance at a wavelength of 610 nm was measured.

(4)  結果:第1図から明らかなように過酸化水素
の検量線は良好な直線性を示した。また呈色の安定性も
十分であった。
(4) Results: As is clear from FIG. 1, the calibration curve for hydrogen peroxide showed good linearity. Furthermore, the stability of color development was also sufficient.

実施例2 尿酸の定量: (1)  原理:尿酸にウリカーゼを作用させ定量的に
生成する過酸化水素をパーオキシダーゼと本発明化合物
を用いて測定しその値から尿酸を定量する。
Example 2 Quantification of uric acid: (1) Principle: Uricase is reacted with uric acid to quantitatively produce hydrogen peroxide, which is measured using peroxidase and the compound of the present invention, and uric acid is determined from that value.

(2)  試薬: 70 m mol/lホウ酸塩緩衝
液(−6)Kウリカーゼ0.2U/d、/#−オキシダ
ーゼ0.5U/sd、本発明化合物A450μmol/
lの濃度になるよう調製した。
(2) Reagents: 70 mmol/l borate buffer (-6) K uricase 0.2 U/d, /#-oxidase 0.5 U/sd, present compound A 450 μmol/
The concentration was adjusted to 1.

(3)  操作:試薬3.OdK血清20μtを加え、
37℃で15分間加温し、波長610 nmの吸光度を
測定した。
(3) Operation: Reagent 3. Add 20μt of OdK serum,
It was heated at 37° C. for 15 minutes, and the absorbance at a wavelength of 610 nm was measured.

別に作製した検量線を用いて尿酸を定量した。Uric acid was quantified using a separately prepared calibration curve.

(4)検量線の作製:尿酸を水[ff!解し、1.5゜
L2 * 0−9 @ 0−6 * Oa3 m mo
1/L Kなるよう尿酸試料液を調製した。
(4) Preparation of calibration curve: uric acid with water [ff! 1.5゜L2 * 0-9 @ 0-6 * Oa3 m mo
A uric acid sample solution was prepared to be 1/L K.

これを用い血清の場合と同様に操作し夫々の吸光度を測
定し第2図の検量線を得た。これは良好な直線性を示し
た。また試薬は使用上十分な保存安定性のあることが確
關され九
This was used in the same manner as in the case of serum, and the respective absorbances were measured to obtain the calibration curve shown in Figure 2. It showed good linearity. It has also been confirmed that the reagent has sufficient storage stability for use.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は本発明の試薬を用いる過酸化水素は 測定の検量線を示し、第2図P本発明の試薬を用いる尿
fII測定の検量線を示す。 ′cJll田 逍蘇4しに宛l(ルームノ zB 瓜献1(、、、、J/l)
FIG. 1 shows a calibration curve for hydrogen peroxide measurement using the reagent of the present invention, and FIG. 2 P shows a calibration curve for urine fII measurement using the reagent of the present invention. 'cJll Tashoso 4 Shini address l (room nozB urination 1 (,,,,J/l)

Claims (2)

【特許請求の範囲】[Claims] (1)次の一般式で表わされる化合物あるいはその塩を
発色剤として含有することを特徴とする液体中の過酸化
水素定量用試薬。 (ここでR1は−H,−QC島、−C為R2は−σ馬、
へC,I’l。 Rj ハ+CHt +、 80s Hf ?、= it
+CH1+IC0OHでH== l 〜3を表わす)
(1) A reagent for quantifying hydrogen peroxide in a liquid, which contains a compound represented by the following general formula or a salt thereof as a coloring agent. (Here, R1 is -H, -QC island, -C and R2 is -σ horse,
To C, I'l. Rj Ha+CHt+, 80s Hf? , = it
+CH1+IC0OH represents H== l ~ 3)
(2)物質に作用し、最終的に過酸化水素を生成する一
連の反応にあずかる全ての試薬成分、パーオキシダーゼ
またはノ臂−オキシダーゼよう作用を有する物質および
特許請求の範囲第1項に記載の化合物からなる当該物質
の定量用試薬。
(2) All reagent components that act on a substance and participate in a series of reactions that ultimately produce hydrogen peroxide, substances that have peroxidase or arm oxidase-like action, and the claims set forth in claim 1. A reagent for quantifying the substance consisting of a compound.
JP14392481A 1981-09-14 1981-09-14 Reagent for quantitative determination of hydrogen peroxide Granted JPS5845557A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP14392481A JPS5845557A (en) 1981-09-14 1981-09-14 Reagent for quantitative determination of hydrogen peroxide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14392481A JPS5845557A (en) 1981-09-14 1981-09-14 Reagent for quantitative determination of hydrogen peroxide

Publications (2)

Publication Number Publication Date
JPS5845557A true JPS5845557A (en) 1983-03-16
JPH0218840B2 JPH0218840B2 (en) 1990-04-26

Family

ID=15350258

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14392481A Granted JPS5845557A (en) 1981-09-14 1981-09-14 Reagent for quantitative determination of hydrogen peroxide

Country Status (1)

Country Link
JP (1) JPS5845557A (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0122641A2 (en) * 1983-04-18 1984-10-24 Fuji Photo Film Co., Ltd. Analytical reagent, analytical method, and multilayer chemical-analytical element
EP0165588A2 (en) * 1984-06-19 1985-12-27 Fuji Photo Film Co., Ltd. Analytical reagent, analytical method, and multilayer chemical-analytical element
JPH0236352A (en) * 1988-06-13 1990-02-06 Eastman Kodak Co Imidasol leuco dye component containing 4'-hydroxy acetanilide, diagnosis kit and use thereof
US5024935A (en) * 1987-12-18 1991-06-18 Eastman Kodak Company Dye-providing composition, diagnostic test kit and their use in method for ligand determination using peroxidase labeled-receptor
EP0603953A1 (en) * 1992-12-22 1994-06-29 Johnson &amp; Johnson Clinical Diagnostics, Inc. Use of 4' of 5'-hydroxy and 4'- or 5'-alkoxy-substituted electron transfer agents in compositions, elements, test kits and analytical methods
EP0693552A2 (en) 1994-07-19 1996-01-24 JOHNSON &amp; JOHNSON CLINICAL DIAGNOSTICS, INC. Analytical element, composition and method using modified apo-horseradish peroxidase
US7276379B2 (en) 2001-05-29 2007-10-02 Nihon Trim Co., Ltd. Detection method and quantitative analysis method for hydrogen radical
EP2141180A1 (en) 2008-06-30 2010-01-06 Fujifilm Corporation Antibody recognizing canine CRP and human CRP
EP2336158A1 (en) 2009-12-21 2011-06-22 Fujifilm Corporation Dry analytical element for measurement of canine CRP

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5326188A (en) * 1976-08-09 1978-03-10 Eastman Kodak Co Composition for detecting hydrogen peroxide
JPS5642599A (en) * 1979-09-13 1981-04-20 Wako Pure Chem Ind Ltd Novel method of hydrogen peroxide determination

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5326188A (en) * 1976-08-09 1978-03-10 Eastman Kodak Co Composition for detecting hydrogen peroxide
JPS5642599A (en) * 1979-09-13 1981-04-20 Wako Pure Chem Ind Ltd Novel method of hydrogen peroxide determination

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0122641A2 (en) * 1983-04-18 1984-10-24 Fuji Photo Film Co., Ltd. Analytical reagent, analytical method, and multilayer chemical-analytical element
JPS59193352A (en) * 1983-04-18 1984-11-01 Fuji Photo Film Co Ltd Reagent for analysis, method of analysis and element of multiple chemical analysis
JPH0319505B2 (en) * 1983-04-18 1991-03-15 Fuji Photo Film Co Ltd
EP0165588A2 (en) * 1984-06-19 1985-12-27 Fuji Photo Film Co., Ltd. Analytical reagent, analytical method, and multilayer chemical-analytical element
US4721670A (en) * 1984-06-19 1988-01-26 Fuji Photo Film Co., Ltd. Analytical reagent, analytical method, and multilayer chemical-analytical element
US5024935A (en) * 1987-12-18 1991-06-18 Eastman Kodak Company Dye-providing composition, diagnostic test kit and their use in method for ligand determination using peroxidase labeled-receptor
JPH0236352A (en) * 1988-06-13 1990-02-06 Eastman Kodak Co Imidasol leuco dye component containing 4'-hydroxy acetanilide, diagnosis kit and use thereof
EP0603953A1 (en) * 1992-12-22 1994-06-29 Johnson &amp; Johnson Clinical Diagnostics, Inc. Use of 4' of 5'-hydroxy and 4'- or 5'-alkoxy-substituted electron transfer agents in compositions, elements, test kits and analytical methods
EP0693552A2 (en) 1994-07-19 1996-01-24 JOHNSON &amp; JOHNSON CLINICAL DIAGNOSTICS, INC. Analytical element, composition and method using modified apo-horseradish peroxidase
US7276379B2 (en) 2001-05-29 2007-10-02 Nihon Trim Co., Ltd. Detection method and quantitative analysis method for hydrogen radical
EP2141180A1 (en) 2008-06-30 2010-01-06 Fujifilm Corporation Antibody recognizing canine CRP and human CRP
EP2336158A1 (en) 2009-12-21 2011-06-22 Fujifilm Corporation Dry analytical element for measurement of canine CRP

Also Published As

Publication number Publication date
JPH0218840B2 (en) 1990-04-26

Similar Documents

Publication Publication Date Title
EP1224240B1 (en) 8-(anilino)-1-naphthalenesulfonate analogs and their use in analyte detection assays
JP3342077B2 (en) Improved oxidative coupling dyes for spectrophotometric determination of analytes
KR101282539B1 (en) Method of multiquantification for cholesterol of low-density lipoprotein
US5516700A (en) Automated urinalysis method
JPS6129462B2 (en)
EP0223977B1 (en) Colour developing method in clinical examinations
EP0122641B1 (en) Analytical reagent, analytical method, and multilayer chemical-analytical element
JPS6134799B2 (en)
EP0243066B1 (en) Element and method for the determination of creatinine or creatine
JPS5845557A (en) Reagent for quantitative determination of hydrogen peroxide
JPS6310775A (en) 2-hydrazono-4,6-dinitrobenzthiazolone
CN106367471A (en) Kit for measuring total cholesterol and method
EP0797774B1 (en) Multilayer analytical element
JP3569139B2 (en) Diazonium ion assay reagent and method of use
JPS59162899A (en) Method and composition for determination of beta-hydroxybutyric acid
JP3065692B2 (en) Naphthotriazolium salt
US8101374B2 (en) Oxidative chromogenic compound or salt thereof and production method thereof, and reagent composition and test instrument using the same
JP2516381B2 (en) Method for quantifying hydrogen peroxide and reagent for quantifying the same
JPWO2006030866A1 (en) Method for quantitative determination of uric acid
JPH07116382B2 (en) Water-soluble methylenebisdialkylaniline derivative and its salts, and composition for quantifying peroxides using the same
JP2805805B2 (en) Method for measuring superoxide dismutase and reagent for measurement
JPS6342470A (en) Method for measuring peroxidase or h2o2
JPH0675072B2 (en) Indirect bilirubin assay and kit
JPH0244519B2 (en)
JPH0244396B2 (en) BIRIRUBINTEIRYOHO